Teriparatide Acetate CAS: 99294-94-7
Product Detail
Name: Teriparatide Acetate
Feature:
Bone metabolism is mediated by inhibiting osteoblast apoptosis, activating bone lining cells and enhancing osteoblast differentiation. The PHT-I receptor on the surface of osteoblasts, bone lining cells and bone marrow stromal stem cells is intermittently stimulated by regulating the adenylate cyclase – cyclic adenosine monophosphate – protein kinase A conduction pathway to promote the differentiation of osteoblasts and prolong the life of osteoblasts; Stimulate the proliferation of osteoblast cell line through phosphate C-cytoplasmic calcium ion-protein kinase C signal chemicalbook signal transduction pathway; By suppressing PPAR γ The trans-activation activity of osteoclast can reduce the differentiation of stromal cells into adipocyte lines and increase the number of osteoblasts; Indirectly regulate bone growth by regulating cytokines, for example, it can induce iGF-1 to combine with osteoblasts, thus promoting bone formation; The process of bone formation is regulated by Wnt signal pathway, thus increasing bone formation.
Composition:
Assay: 99%
Appearance: White powder
CAS No. 52232-67-4;99294-94-7
Packing: 25kg
Shelf Life: 2 years
Storage: Store in cool and dry area
Certification:ISO.
![1H-BenziMidazole-7-carboxylic acid, 1-[[2'-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]Methyl] -2-ethoxy-, Methyl ester CAS:147403-52-9](https://cdnus.globalso.com/puyerinternationalgroup/1951-300x300.png)
